 |
PDBsum entry 1w6m
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Sugar binding protein
|
PDB id
|
|
|
|
1w6m
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Sugar binding protein
|
 |
|
Title:
|
 |
X-ray crystal structure of c2s human galectin-1 complexed with galactose
|
|
Structure:
|
 |
Galectin-1. Chain: a. Synonym: beta-galactoside-binding lectin l-14-i, hpl, lactose-binding lectin 1, s-lac lectin 1, galaptin, hbl. Engineered: yes. Mutation: yes. Galectin-1. Chain: b. Synonym: beta-galactoside-binding lectin l-14-i, lactose-binding
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.201
|
R-free:
|
0.241
|
|
|
Authors:
|
 |
M.I.F.Lopez-Lucendo,H.J.Gabius,A.Romero
|
Key ref:
|
 |
M.F.López-Lucendo
et al.
(2004).
Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding.
J Mol Biol,
343,
957-970.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-Aug-04
|
Release date:
|
20-Oct-04
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P09382
(LEG1_HUMAN) -
Galectin-1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
135 a.a.
134 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
343:957-970
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding.
|
|
M.F.López-Lucendo,
D.Solís,
S.André,
J.Hirabayashi,
K.Kasai,
H.Kaltner,
H.J.Gabius,
A.Romero.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human galectin-1 is a potent multifunctional effector that participates in
specific protein-carbohydrate and protein-protein (lipid) interactions. By
determining its X-ray structure, we provide the basis to define the structure of
its ligand-binding pocket and to perform rational drug design. We have also
analysed whether single-site mutations introduced at some distance from the
carbohydrate recognition domain can affect the lectin fold and influence sugar
binding. Both the substitutions introduced in the C2S and R111H mutants altered
the presentation of the loop, harbouring Asp123 in the common
"jelly-roll" fold. The orientation of the side-chain was inverted 180
degrees and the positions of two key residues in the sugar-binding site of the
R111H mutant were notably shifted, i.e. His52 and Trp68. Titration calorimetry
was used to define the decrease in ligand affinity in both mutants and a
significant increase in the entropic penalty was found to outweigh a slight
enhancement of the enthalpic contribution. The position of the SH-groups in the
galectin appeared to considerably restrict the potential to form intramolecular
disulphide bridges and was assumed to be the reason for the unstable lectin
activity in the absence of reducing agent. However, this offers no obvious
explanation for the improved stability of the C2S mutant under oxidative
conditions. The noted long-range effects in single-site mutants are relevant for
the functional divergence of closely related galectins and in more general
terms, the functionality definition of distinct amino acids.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Ribbon diagram of the homodimeric human
galectin-1 prepared with MOLSCRIPT.70 The b-strands in the
five-stranded (F1-F5) and six-stranded (S1-S6a/S6b) b-sheets are
indicated by the letter-number code.
|
 |
Figure 5.
Figure 5. The carbohydrate recognition site of hGal-1. (a)
The binding site in free hGal-1, showing the position of bound
water molecules as green spheres. The three water molecules are
placed at the sites of interaction with the hydroxyl groups O4,
O6 of galactose and O3 of glucose, when the ligand enters the
binding site. (b) A view of the CRD of wt hGal-1 complexed with
lactose. The carbohydrate-binding cleft is discernible in the
concave face of the S4-S6a/S6b b-sheet. The lactose moiety and
the side-chains of the sugar-binding residues are shown as
stick-and-ball models.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2004,
343,
957-970)
copyright 2004.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Kaltner,
D.Kübler,
L.López-Merino,
M.Lohr,
J.C.Manning,
M.Lensch,
J.Seidler,
W.D.Lehmann,
S.André,
D.Solís,
and
H.J.Gabius
(2011).
Toward Comprehensive Analysis of the Galectin Network in Chicken: Unique Diversity of Galectin-3 and Comparison of its Localization Profile in Organs of Adult Animals to the Other Four Members of this Lectin Family.
|
| |
Anat Rec (Hoboken),
294,
427-444.
|
 |
|
|
|
|
 |
H.Sanchez-Ruderisch,
K.M.Detjen,
M.Welzel,
S.André,
C.Fischer,
H.J.Gabius,
and
S.Rosewicz
(2011).
Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrin.
|
| |
Cell Death Differ,
18,
806-816.
|
 |
|
|
|
|
 |
I.Echeverria,
and
L.M.Amzel
(2011).
Disaccharide binding to galectin-1: free energy calculations and molecular recognition mechanism.
|
| |
Biophys J,
100,
2283-2292.
|
 |
|
|
|
|
 |
E.M.Rapoport,
T.V.Pochechueva,
O.V.Kurmyshkina,
G.V.Pazynina,
V.V.Severov,
E.A.Gordeeva,
I.M.Belyanchikov,
S.André,
H.J.Gabius,
and
N.V.Bovin
(2010).
Solid-phase assays for study of carbohydrate specificity of galectins.
|
| |
Biochemistry (Mosc),
75,
310-319.
|
 |
|
|
|
|
 |
K.E.Kövér,
E.Wéber,
T.A.Martinek,
E.Monostori,
and
G.Batta
(2010).
(15)N and (13)C group-selective techniques extend the scope of STD NMR detection of weak host-guest interactions and ligand screening.
|
| |
Chembiochem,
11,
2182-2187.
|
 |
|
|
|
|
 |
M.Dias-Baruffi,
S.R.Stowell,
S.C.Song,
C.M.Arthur,
M.Cho,
L.C.Rodrigues,
M.A.Montes,
M.A.Rossi,
J.A.James,
R.P.McEver,
and
R.D.Cummings
(2010).
Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle.
|
| |
Glycobiology,
20,
507-520.
|
 |
|
|
|
|
 |
M.Pasek,
E.Boeggeman,
B.Ramakrishnan,
and
P.K.Qasba
(2010).
Galectin-1 as a fusion partner for the production of soluble and folded human beta-1,4-galactosyltransferase-T7 in E. coli.
|
| |
Biochem Biophys Res Commun,
394,
679-684.
|
 |
|
|
|
|
 |
M.Tamura,
T.Igarashi,
K.Kasai,
and
Y.Arata
(2010).
Side chain orientation of the amino acid substituted by a cysteine residue is important for successful crosslinking of galectin to its glycoprotein ligand using a photoactivatable sulfhydryl reagent.
|
| |
Yakugaku Zasshi,
130,
1375-1379.
|
 |
|
|
|
|
 |
S.Kalkhof,
S.Haehn,
M.Paulsson,
N.Smyth,
J.Meiler,
and
A.Sinz
(2010).
Computational modeling of laminin N-terminal domains using sparse distance constraints from disulfide bonds and chemical cross-linking.
|
| |
Proteins,
78,
3409-3427.
|
 |
|
|
|
|
 |
C.Meynier,
M.Feracci,
M.Espeli,
F.Chaspoul,
P.Gallice,
C.Schiff,
F.Guerlesquin,
and
P.Roche
(2009).
NMR and MD investigations of human galectin-1/oligosaccharide complexes.
|
| |
Biophys J,
97,
3168-3177.
|
 |
|
|
|
|
 |
J.Tejler,
B.Salameh,
H.Leffler,
and
U.J.Nilsson
(2009).
Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3.
|
| |
Org Biomol Chem,
7,
3982-3990.
|
 |
|
|
|
|
 |
M.C.Miller,
A.Klyosov,
and
K.H.Mayo
(2009).
The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain.
|
| |
Glycobiology,
19,
1034-1045.
|
 |
|
|
|
|
 |
M.C.Miller,
I.V.Nesmelova,
D.Platt,
A.Klyosov,
and
K.H.Mayo
(2009).
The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface.
|
| |
Biochem J,
421,
211-221.
|
 |
|
|
|
|
 |
M.Nagae,
N.Nishi,
T.Murata,
T.Usui,
T.Nakamura,
S.Wakatsuki,
and
R.Kato
(2009).
Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.
|
| |
Glycobiology,
19,
112-117.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Shimizu,
J.Khoshnoodi,
Y.Akimoto,
H.Kawakami,
H.Hirano,
E.Higashihara,
M.Hosoyamada,
Y.Sekine,
R.Kurayama,
H.Kurayama,
K.Joh,
J.Hirabayashi,
K.Kasai,
K.Tryggvason,
N.Ito,
and
K.Yan
(2009).
Expression of galectin-1, a new component of slit diaphragm, is altered in minimal change nephrotic syndrome.
|
| |
Lab Invest,
89,
178-195.
|
 |
|
|
|
|
 |
O.Roda,
E.Ortiz-Zapater,
N.Martínez-Bosch,
R.Gutiérrez-Gallego,
M.Vila-Perelló,
C.Ampurdanés,
H.J.Gabius,
S.André,
D.Andreu,
F.X.Real,
and
P.Navarro
(2009).
Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.
|
| |
Gastroenterology,
136,
1379.
|
 |
|
|
|
|
 |
S.D'Auria,
L.Petrova,
C.John,
G.Russev,
A.Varriale,
and
V.Bogoeva
(2009).
Tumor-specific protein human galectin-1 interacts with anticancer agents.
|
| |
Mol Biosyst,
5,
1331-1336.
|
 |
|
|
|
|
 |
S.Di Lella,
L.Ma,
J.C.Ricci,
G.A.Rabinovich,
S.A.Asher,
and
R.M.Alvarez
(2009).
Critical role of the solvent environment in galectin-1 binding to the disaccharide lactose.
|
| |
Biochemistry,
48,
786-791.
|
 |
|
|
|
|
 |
S.R.Stowell,
M.Cho,
C.L.Feasley,
C.M.Arthur,
X.Song,
J.K.Colucci,
S.Karmakar,
P.Mehta,
M.Dias-Baruffi,
R.P.McEver,
and
R.D.Cummings
(2009).
Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation.
|
| |
J Biol Chem,
284,
4989-4999.
|
 |
|
|
|
|
 |
A.D.Hill,
and
P.J.Reilly
(2008).
A Gibbs free energy correlation for automated docking of carbohydrates.
|
| |
J Comput Chem,
29,
1131-1141.
|
 |
|
|
|
|
 |
C.E.Maljaars,
A.C.de Souza,
K.M.Halkes,
P.J.Upton,
S.M.Reeman,
S.André,
H.J.Gabius,
M.B.McDonnell,
and
J.P.Kamerling
(2008).
The application of neoglycopeptides in the development of sensitive surface plasmon resonance-based biosensors.
|
| |
Biosens Bioelectron,
24,
60-65.
|
 |
|
|
|
|
 |
D.Zhou,
H.Ge,
J.Sun,
Y.Gao,
M.Teng,
and
L.Niu
(2008).
Crystal structure of the C-terminal conserved domain of human GRP, a galectin-related protein, reveals a function mode different from those of galectins.
|
| |
Proteins,
71,
1582-1588.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.M.Rapoport,
O.V.Kurmyshkina,
and
N.V.Bovin
(2008).
Mammalian galectins: structure, carbohydrate specificity, and functions.
|
| |
Biochemistry (Mosc),
73,
393-405.
|
 |
|
|
|
|
 |
M.A.Wälti,
S.Thore,
M.Aebi,
and
M.Künzler
(2008).
Crystal structure of the putative carbohydrate recognition domain of human galectin-related protein.
|
| |
Proteins,
72,
804-808.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.G.Than,
O.Erez,
D.E.Wildman,
A.L.Tarca,
S.S.Edwin,
A.Abbas,
J.Hotra,
J.P.Kusanovic,
F.Gotsch,
S.S.Hassan,
J.Espinoza,
Z.Papp,
and
R.Romero
(2008).
Severe preeclampsia is characterized by increased placental expression of galectin-1.
|
| |
J Matern Fetal Neonatal Med,
21,
429-442.
|
 |
|
|
|
|
 |
N.G.Than,
R.Romero,
O.Erez,
A.Weckle,
A.L.Tarca,
J.Hotra,
A.Abbas,
Y.M.Han,
S.S.Kim,
J.P.Kusanovic,
F.Gotsch,
Z.Hou,
J.Santolaya-Forgas,
K.Benirschke,
Z.Papp,
L.I.Grossman,
M.Goodman,
and
D.E.Wildman
(2008).
Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance.
|
| |
Proc Natl Acad Sci U S A,
105,
15819-15824.
|
 |
|
|
|
|
 |
N.Nishi,
A.Abe,
J.Iwaki,
H.Yoshida,
A.Itoh,
H.Shoji,
S.Kamitori,
J.Hirabayashi,
and
T.Nakamura
(2008).
Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1.
|
| |
Glycobiology,
18,
1065-1073.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
O.Charvátová,
B.L.Foley,
M.W.Bern,
J.S.Sharp,
R.Orlando,
and
R.J.Woods
(2008).
Quantifying protein interface footprinting by hydroxyl radical oxidation and molecular dynamics simulation: application to galectin-1.
|
| |
J Am Soc Mass Spectrom,
19,
1692-1705.
|
 |
|
|
|
|
 |
R.Suzuki,
J.Wada,
T.Katayama,
S.Fushinobu,
T.Wakagi,
H.Shoun,
H.Sugimoto,
A.Tanaka,
H.Kumagai,
H.Ashida,
M.Kitaoka,
and
K.Yamamoto
(2008).
Structural and thermodynamic analyses of solute-binding Protein from Bifidobacterium longum specific for core 1 disaccharide and lacto-N-biose I.
|
| |
J Biol Chem,
283,
13165-13173.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.D.Disney,
and
J.L.Childs-Disney
(2007).
"Supra"molecular recognition of Galectin 1.
|
| |
Chem Biol,
14,
1095-1097.
|
 |
|
|
|
|
 |
S.A.Scott,
K.Scott,
and
H.Blanchard
(2007).
Crystallization and preliminary crystallographic analysis of recombinant human galectin-1.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
63,
967-971.
|
 |
|
|
|
|
 |
S.André,
H.Sanchez-Ruderisch,
H.Nakagawa,
M.Buchholz,
J.Kopitz,
P.Forberich,
W.Kemmner,
C.Böck,
K.Deguchi,
K.M.Detjen,
B.Wiedenmann,
M.von Knebel Doeberitz,
T.M.Gress,
S.Nishimura,
S.Rosewicz,
and
H.J.Gabius
(2007).
Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.
|
| |
FEBS J,
274,
3233-3256.
|
 |
|
|
|
|
 |
K.Smetana,
B.Dvoránková,
M.Chovanec,
J.Boucek,
J.Klíma,
J.Motlík,
M.Lensch,
H.Kaltner,
S.André,
and
H.J.Gabius
(2006).
Nuclear presence of adhesion-/growth-regulatory galectins in normal/malignant cells of squamous epithelial origin.
|
| |
Histochem Cell Biol,
125,
171-182.
|
 |
|
|
|
|
 |
M.Lensch,
M.Lohr,
R.Russwurm,
M.Vidal,
H.Kaltner,
S.André,
and
H.J.Gabius
(2006).
Unique sequence and expression profiles of rat galectins-5 and -9 as a result of species-specific gene divergence.
|
| |
Int J Biochem Cell Biol,
38,
1741-1758.
|
 |
|
|
|
|
 |
M.Martín-Pastor,
M.Vega-Vázquez,
A.De Capua,
A.Canales,
S.André,
H.J.Gabius,
and
J.Jiménez-Barbero
(2006).
Enhanced signal dispersion in saturation transfer difference experiments by conversion to a 1D-STD-homodecoupled spectrum.
|
| |
J Biomol NMR,
36,
103-109.
|
 |
|
|
|
|
 |
M.Nagae,
N.Nishi,
T.Murata,
T.Usui,
T.Nakamura,
S.Wakatsuki,
and
R.Kato
(2006).
Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.
|
| |
J Biol Chem,
281,
35884-35893.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.J.Pieters
(2006).
Inhibition and detection of galectins.
|
| |
Chembiochem,
7,
721-728.
|
 |
|
|
|
|
 |
S.Saussez,
F.Lorfevre,
D.Nonclercq,
G.Laurent,
S.André,
F.Journé,
R.Kiss,
G.Toubeau,
and
H.J.Gabius
(2006).
Towards functional glycomics by localization of binding sites for tissue lectins: lectin histochemical reactivity for galectins during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster.
|
| |
Histochem Cell Biol,
126,
57-69.
|
 |
|
|
|
|
 |
C.Fischer,
H.Sanchez-Ruderisch,
M.Welzel,
B.Wiedenmann,
T.Sakai,
S.André,
H.J.Gabius,
L.Khachigian,
K.M.Detjen,
and
S.Rosewicz
(2005).
Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27.
|
| |
J Biol Chem,
280,
37266-37277.
|
 |
|
|
|
|
 |
C.Seelenmeyer,
S.Wegehingel,
I.Tews,
M.Künzler,
M.Aebi,
and
W.Nickel
(2005).
Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1.
|
| |
J Cell Biol,
171,
373-381.
|
 |
|
|
|
|
 |
S.André,
S.Kojima,
I.Prahl,
M.Lensch,
C.Unverzagt,
and
H.J.Gabius
(2005).
Introduction of extended LEC14-type branching into core-fucosylated biantennary N-glycan.
|
| |
FEBS J,
272,
1986-1998.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |